Elanco Animal Health Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 535.00 M

Elanco Animal Health Incorporated Operating Cash Flow is USD 535.00 M for the Trailing 12 Months (TTM) ending March 31, 2025, a 27.99% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
  • Elanco Animal Health Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 418.00 M, a 13.28% change year over year.
  • Elanco Animal Health Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 369.00 M, a -7.52% change year over year.
  • Elanco Animal Health Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 399.00 M, a -1,812.45% change year over year.
  • Elanco Animal Health Incorporated Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD -23.30 M, a -110.46% change year over year.
Key Data
Date Operating Cash Flow Capital Expenditure Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities